Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Peab renovates and extends upper secondary school in Helsinki

Peab has been commissioned to renovate the upper secondary school Lärkan in Helsinki. The customer is the City of Helsinki and the contract is worth EUR 18 million.The upper secondary school is a culturally historic valuable building from 1962 which has not yet undergone a complete renovation. This has left many original surfaces and constructions intact. The renovation, which comprises the building’s facades, windows, outer doors and constructions, will be carried out so that the school’s characteristic features are preserved. All technology and classroom equipment will be updated as well.

OssDsign reaches commercial milestone of 750 implants sold in Germany

Uppsala, April 27, 2023. OssDsign AB (publ.) today announces that the company has reached the commercial milestone of 750 implants sold in Germany since market entry, with a significant acceleration in sales during the last two years.Germany is one of the most important markets in Europe and, in recent years, OssDsign has considerably increased its sales efforts in Germany, resulting in a significant acceleration in sales. In addition to this, the company has successfully delivered on its strategic priority to increase operational efficiency and reduce lead time for OssDsign Cranial PSI.

Stille AB: Interim Report Q1 2023

Stille AB (publ) publishes the report for the first quarter of the business year 2023. ”Good start – strong sales growth and significantly improved operating cashflow”, summarizes President and CEO Torbjörn Sköld.Revenues increased in the first quarter by 17.5 percent to 72.4 (61.6) after strong growth from both business units. “I am satisfied to see such strong growth compared to previous year given that the first quarter last year was a record quarter”, comments Torbjörn Sköld. The gross profit amounted to 42.4 percent (44.8). Business unit Surgical Tables was affected by an

Norse Atlantic ASA: Ex. reverse share split today

Issuer name: Norse Atlantic ASA Ex. date: 27 April 2023 Type of corporate action: reverse share split Ratio: four (4) old shares give one (1) new share New ISIN: NO 0012885252This information is published in accordance with the requirements of the Continuing Obligations. For further information, please contact: Ben Boiling, CFO Phone: +47 912 40 945 Email: ben.boiling@flynorse.com About Norse Atlantic ASA: Norse Atlantic Airways is a new airline that offers affordable fares on long -haul flights, primarily between Europe and the United States. The company was

Orexo Interim Report Q1 2023

Focusing operations on Orexo´s strengths Q1 2023 highlights · Total net revenues of SEK 158.8 m (159.4) · EBITDA of SEK -41.1 m (2.8), EBITDA excluding legal costs and costs for non-repeating clinical trials, SEK 20.9 m (32.2)  · Net earnings of SEK -63.9 m (-23.6) · US Pharma segment (ZUBSOLV® US) net revenues of SEK 140.3 m (139.1), in local currency USD 13.5 m (14.8), US Pharma EBIT of SEK 74.3 m (84.0) · Cash flow from operating activities of SEK -61.6 m (-61.6), cash and invested funds of SEK 278.9 m (437.8) · Earnings per share before and after dilution amounted

Interim report January – March 2023

FIRST QUARTER · Revenues amounted to MSEK 482.8 (MSEK 476.1), an increase by 1 % compared to the same period last year. · Operating profit amounted to MSEK 155.7 (MSEK 208.5), a decrease by 25 %. · Profit after financial items amounted to MSEK 157.1 (MSEK 207.7), and profit after tax amounted to MSEK 123.7 (MSEK 168.5). · Cash flow from operating activities amounted to MSEK 244.6 (MSEK 236.4), and cash flow from investing activities amounted to MSEK -170.1 (MSEK -157.4). · By the end of the period cash amounted to MSEK 812.7 (MSEK 671.2). · Earnings per share before

OKEA first quarter 2023 trading update

(Trondheim, 27 April 2023) OKEA ASA (OSE: OKEA) will publish its financial report for the first quarter of 2023 on Thursday 4 May at 06:00 (CET). This trading update is provided to summarise production and sales volumes and related topics and updates for the quarter.(Amounts in parentheses refer to previous quarter) First quarter 2023 production and sales Unit Q1 2023 Q4 2022Total operating income MNOK 2,954 1,664Realised liquids price USD/boe* 77.7 95.2Realised gas price

JM Interim Report January–March 2023

Challenging housing market in weak economy  • Revenue increased to SEK 3,962m (3,854). • Operating profit decreased to SEK 417m (466). The operating margin decreased to 10.5 percent (12.1). • Profit before tax decreased to SEK 394m (450), and profit after tax decreased to SEK 311m (356). • Return on equity for the past twelve months amounted to 16.8 percent (22.6). • Earnings per share amounted to SEK 4.80 (5.20). • Consolidated cash flow including net investment in properties amounted to SEK 792m (273). • The number of residential units sold decreased to 479 (995)

Finnair Group Interim Report 1 January – 31 March 2023

Finnair Plc                  Interim Report                 27 April 2023 at 9.00 a.m. EEST Strong demand and well-progressed strategy implementation led to break-even result during seasonally weakest quarter. January – March 2023                                   · Earnings per share were -0.01 euros (-0.15)*. · Revenue increased by 73.8% to 694.7 million euros (399.8). · Comparable operating result was 0.9 million euros (-132.9). Operating result was 8.3 million euros (-164.9). · High fuel price had an adverse cost impact of c. 40 million euros** year-on-year. ·

SKF First-quarter report 2023: Strong organic sales and positive margin trend

Gothenburg, 27 April 2023 Rickard Gustafson, President and CEO: “Review of the first quarterI’m pleased to report a solid quarter with strong organic sales growth and a record high adjusted operating profit for a first quarter. In the period, we delivered an organic sales growth of more than 10%, with continued robust demand across all our regions. Most of our targeted high-growth segments contributed with double-digit growth, e.g. railway, renewable energy and aero­space. The adjusted operating profit improved to SEK 3,478 million (3,058), with an adjusted operating margin of

Midsona - Interim Report January-March 2023

Improved gross margin and continued strong cash flow January–March 2023 (first quarter)● Net sales amounted to SEK 974 million (972). ● EBITDA, before items affecting comparability, amounted to SEK 60 million (62), corresponding to a margin of 6.2 percent (6.4) and EBITDA amounted to SEK 55 million (62). ● Operating profit, before items affecting comparability, amounted to SEK 21 million (22), corresponding to a margin of 2.2 percent (2.3) and the operating profit amounted to SEK 16 million (22). ● The profit/loss for the period was SEK –6 million (12), corresponding to earnings/

Interim report Q1, January - March 2023

Summary January - March 2023• Net sales amounted to SEK 87.4 (75.6) million, an increase of 15.6 percent compared to the corresponding period last year. Currency-adjusted growth amounted to 11.0 percent.• EBIT amounted to SEK 8.2 (-0.2) million, corresponding to an EBIT margin of 9.3 (-0.3) percent.• Profit after tax amounted to SEK 6.7 (1.4) million.• Earnings per share before/after dilution amounted to SEK 0.36 (0.07).• Cash flow from operating activities increased to SEK 24.0 (5.5) million, in addition to the results for the period and driven primarily by a positive change in

Sobi publishes Q1 2023 report: Continued solid progress

Swedish Orphan Biovitrum AB (publ)  (Sobi®) today announced its reportfor the first quarter of 2023   First quarter 2023 •          Total revenue SEK 5,239 M (4,925), +6 per cent, -2 per cent at constant exchange rates (CER).[i] •          Haematology revenue SEK 2,815 M (2,499), +5 per cent at CER of which Elocta® SEK 1,196 M (1,024), +9 per cent at CER; Alprolix® SEK 514 M (419), +16 per cent at CER; Doptelet® SEK 475 M (593), -28 per cent at CER and Aspaveli®/Empaveli® SEK 95 M (4) •          Immunology revenue SEK 2,151 M (2,119), -9 per cent at

NORDIC MINING: Resignation of CFO

Nordic Mining ASA (“Nordic Mining” or the “Company”) informs that Christian Gjerde has tendered his resignation from his position as CFO in Nordic Mining to pursue opportunities outside of the Company. The effective date of his resignation will be further agreed with the Company. Nordic Mining will immediately start the process to recruit a successor. “I greatly appreciate the tremendous effort Gjerde has carried out in Nordic Mining, having secured the full financing of Engebø Rutile and Garnet in a challenging market. I wish him best of luck with his career going forward”, says CEO

BioArctic publishes the Annual Report for 2022

Stockholm April 27, 2023 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) hereby announces that the Annual Report for 2022 has been published.The Annual Report, which is attached, can also be downloaded from the company’s website, www.bioarctic.se/en (Investors/Financial reports and presentations).   ---   For further information, please contact:Jan Mattsson, CFO,E-mail: jan.mattsson@bioarctic.sePhone: + 46 70 352 27 72   Oskar Bosson, Vice President Investor Relations & CommunicationsE-mail: oskar.bosson@bioarctic.sePhone: +46 70 410 71 80    This

Careium reports first quarter results 2023

The quarter in summary · Net sales amounted to SEK 194.0 million (178.5), an increase of 8.7 percent. Service sales amounted to 142.5 million (139.4), an increase of 2.2 percent. Product sales amounted to 51.6 million (39.1), an increase of 31.9 percent. · Gross margin amounted to 38.9 percent (39.2). · Operating profit (EBIT) amounted to SEK 7.3 million (-24.3) corresponding to an operating margin of 3.8 percent (-13.6). Operating profit was not affected by restructuring costs nor non-recurring items (-27.8). · Free cash flow amounted to SEK 28.2 million (4.5). · Earnings

Invitation to Q1 Earnings Teleconference

Karnov Group (Nasdaq: KAR) will publish its financial report for the first quarter 2023 on 9 May at around 08.00 a.m. CEST and Management will host a webcasted telephone conference the same day at 09.00 a.m. CEST.Karnov Group’s interim report for the period January – March 2023 will be published on Tuesday 9 May 2023 at around 8.00 a.m. CEST. A webcasted telephone conference will be held at 09.00 a.m. CEST the same day, where CEO Pontus Bodelsson and Interim CFO Leif Mårtensson will present the report and answer questions.   You can follow the presentation via webcast and ask

Detection Technology Plc business review January-March

Detection Technology Plc company announcement 27 April 2023 at 09:00 (EEST) DETECTION TECHNOLOGY PLC BUSINESS REVIEW JANUARY-MARCH 2023 Detection Technology Q1 2023: Sales in medical and security applications in line with expectations, temporary softening in industrial January-March 2023 highlights •     Net sales increased by 12.0% to EUR 22.8 million (20.3) •     Net sales of Industrial Solutions Business Unit (IBU) decreased by -3.0% to EUR 3.4 (3.5) •     Net sales of Medical Business Unit (MBU) increased by 14.6% to EUR 12.0 million (10.5) •     Net sales of

Bactiguard Holding AB’s report for the first quarter 2023

Continued focus on growth and transformationFirst quarter 2023, January-March · Revenues amounted to SEK 61.2 (55.2) million, an increase of 11%. Adjusted for currency effects, revenues decreased by 4%. · Operating loss amounted to SEK 18.7 (16.6) million, an increase of SEK 2.1 million. · EBITDA amounted to SEK -6.6 (-4.0) million, with an EBITDA margin of -10.8% (-7.2%). · Net loss for the period amounted to SEK 22.1 (16.5) million. · Loss per share, before and after dilution, amounted to SEK 0.63 (0.47). · Cash flow from operating activities amounted to SEK -7.7 (-11.

Vattenfall – interim report, January-March 2023

Financial highlights, January-March 2023 · Net sales increased by 62% (53% excluding currency effects) to SEK 96,788 million (59,579) · Underlying operating profit of SEK 9,545 million (9,504) · Operating profit of SEK 16,332 million (12,783) · Profit for the period of SEK 11,818 million (6,064) Business highlights, January-March 2023 · Lower electricity prices and reduced price area differences. · Repair of Ringhals 4 finalised. · Completed divestment of the gas-fired power plant Magnum in the Netherlands. · Important steps in the feasibility study for

Senior Kinnevik profile Joakim Andersson joins Slättö as CFO

Joakim Andersson joins Slättö as new CFO. Joakim has extensive experience from the Swedish investment company Kinnevik, where he held the position of CFO and Head of Strategy, among other roles, for 13 years. His most recent role was CFO at the software company Cint. At Slättö he will be responsible for finance and IT, fund management and financing.Slättö’s ambition is to become the most respected investor within its chosen strategies. To achieve this position, Slättö applies a thematic approach, building scalable platforms for asset development throughout the entire real estate value chain

SimCorp receives takeover offer

SimCorp A/S (SimCorp or the Company) and Deutsche Börse AG (Deutsche Börse or the Offeror) have today entered into an announcement agreement (the Announcement Agreement) pursuant to which Deutsche Börse will make an all-cash voluntary recommended public takeover offer to acquire all of the issued and outstanding shares (except treasury shares) in SimCorp (the Offer). Deutsche Börse is a German stock corporation (in German: "Aktiengesellschaft") under registration number HRB 32232 with the registry court (in German: "Amtsgericht") Frankfurt/Main. The shares in Deutsche Börse are admitted to

SimCorp Q1 2023 Trading Update

Accelerating growth momentum in the first quarter of 2023Q1 2023 financial highlights · In Q1 2023, SimCorp accelerated its growth momentum across all revenue metrics. The growth was driven by the signing of two new customers as well as expansions with current customers, including signed conversions from on-premise to SaaS for two clients. · SimCorp generated reported revenue of EUR 136.3 million in Q1 2023 (Q1 2022: EUR 114.7 million), equivalent to an increase of 18.8% in reported terms and 18.6% when measured in local currencies. The reported growth was driven by 84% SaaS revenue

Interim report January–March 2023

· Revenue amounted to €419.3m (€381.7m), an increase of 9.9% with an organic growth of 4.6%. · Operating profit (EBIT) was €10.7m (€22.2m), representing an operating margin of 2.6% (5.8%). · Net profit amounted to €2.1m (€12.0m), which represents a margin of 0.5% (3.1%). · EBITDA was €54.3m (€62.3m), a decrease by 12.8%. EBITDA margin was 12.9% (16.3%). · EBITDAaL amounted to €30.6m (€42.6m), corresponding to an EBITDAaL margin of 7.3% (11.1%). · Net cash flow from operating activities was €61.4m (€45.8m). · Basic/diluted earnings per share were €0.010 (€0.080).

There are no items matching the current filter
There are no more items matching the current filter
Back to top